Using Machine Learning to Detect Theranostic Biomarkers Predicting Respiratory Treatment Response

Abstract

Background: Theranostic approaches—the use of diagnostics for developing targeted therapies—are gaining popularity in the field of precision medicine. They are predominately used in cancer research, whereas there is little evidence of their use in respiratory medicine. This study aims to detect theranostic biomarkers associated with respiratory-treatment responses. This will advance theory and practice on the use of biomarkers in the diagnosis of respiratory diseases and contribute to developing targeted treatments. Methods: We performed a cross-sectional analysis on a sample of 13,102 adults from the UK household longitudinal study ‘Understanding Society’. We used recursive feature selection to identify 16 biomarkers associated with respiratory treatment responses. We then implemented several machine learning algorithms using the identified biomarkers as well as age, sex, body mass index, and lung function to predict treatment response. Results: Our analysis shows that subjects with increased levels of alkaline phosphatase, glycated haemoglobin, high-density lipoprotein cholesterol, c-reactive protein, triglycerides, hemoglobin, and Clauss fibrinogen are more likely to receive respiratory treatments, adjusting for age, sex, body mass index, and lung function. Conclusions: These findings offer a valuable blueprint on why and how the use of biomarkers as diagnostic tools can prove beneficial in guiding treatment management in respiratory diseases.

Identifying Biomarkers of Cardiovascular Diseases with Machine Learning: Evidence from The UK Household Longitudinal Study

“…Participants with CVDs at follow-up had higher levels of several cardiovascular-related biomarkers at baseline (i.e., triglycerides, c-reactive protein, haemoglobin) than those without CVDs, although these were all within the normal range. 31 Likewise, participants with CVD at follow-up had higher levels of liver disease-related biomarkers (i.e., alkaline phosphatase, alanine transaminase, aspartate transaminase, gamma-glutamyl transferase) than those without CVD, although these were also within normal levels [32] at baseline. Similar patterns were observed for kidney disease-related biomarkers (i.e., creatinine and urea), diabetes-related biomarkers (i.e., glycated haemoglobin), and biomarkers related to hormones (i.e., higher for testosterone and lower for insulin-like-growth factor 1 and dehydroepiandrosterone sulphate).…”

An Automated Method of Causal Inference of the Underlying Cause of Death of Citizens

“…To detect therapeutic biomarkers associated with respiratory-treatment response, Nikolaou et al implemented several machine learning algorithms to predict the treatment response using identified biomarkers as well as age, sex, body mass index and lung function. These findings provide a valuable blueprint for why and how the use of biomarkers as diagnostic tools could prove helpful in guiding the therapeutic management of respiratory diseases [ 20 ].…”